2nd Annual ACMA/DGE

MedComm 3.0

Medical Communications Conference

Register Now
View Agenda

October 21-23, 2019 | Philadelphia, PA

Philadelphia 201 Hotel

Course Overview

In the digital age the pharmaceutical industry relies on their medical communication teams to interpret a tremendous amount of information into user-friendly stories that resonate with audiences. The second annual MedComm 3.0 EAST conference aims to bring industry professionals an interactive platform to explore advanced solutions to communication challenges that the pharmaceutical industry faces.

  • Discuss the changing environment for publications professionals
  • Prioritize medical communications with a scientific platform
  • Break down silos when working with commercial teams
  • Develop frameworks for scientific engagement
  • Discuss the importance of MI omni-channel content strategies
  • Achieve greater transparency and promote practices that protect the integrity of authorship

Learn and network with influential speakers who will share practices they’ve implemented to preserve company reputation and advocate for patients in a highly-regulated environment.

Philadelphia 201 Hotel

Image

201 North 17th Street
Philadelphia, PA 19103
(215) 448-2000
Hotel Website

Special Event Rate
Book Now!

GET DIRECTIONS

MedComm Advisory Board

Image

Renu Juneja

Head of the Scientific Communications and Training
Janssen Biotechnology

Image

Mina Patel

Global Head of Publications
Open Health Group

Image

Jacob Runyan

Director, Scientific Communications
Boehringer Ingelheim

About the Chairperson

Image

Eddie Power, PhD, MBA is currently the VP, North America Medical Affairs, Hospital Business at Pfizer and has held positions of increasing responsibility during his career in the pharmaceutical industry. He has a passionate interest in learning and capability development for Medical Affairs colleagues and led a capability initiative within Pfizer designed to develop medical colleagues’ skills in a variety of behavioral and technical areas. He currently teaches for the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy/Kings College Medicines Development Certification Program.

Monday, October 21st, 2019 | Pre-Conference Workshop


8:00 AM - 9:00 AM

Workshop Registration & Continental Breakfast

9:00 AM - 12:00 PM

MedComm 101 

This workshop is designed for individuals with careers in medical communications or professionals looking to enhance their day-to-day job functions. Join us as we discuss best practices and strategies for addressing the key challenges currently facing the industry.

Learning Objectives:

  • Explore the different roles and responsibilities for MedComm professionals throughout the drug development lifecycle
  • Discuss best practices, resources and ideas to enhance productivity
  • Uncover the latest trends in pharma affecting MedComm
  • Pinpoint strategies to maximize knowledge transfer for day-to-day job functions
  • Define the value proposition associated with Medical Information for internal and external customers
  • Learn how the regulatory environment influences the efficiency of medical communications

Renu JunejaHead, Scientific Evidence Communications, Oncology US Medical Affairs
The Janssen Pharmaceutical Companies of J&J

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 4:00 PM

Develop a Field Medical Strategic Plan 

Successful, strategic development of a field medical plan needs structure and high levels of communication within an organization. To achieve results, you’ll need to be capable of building a solid framework for your strategy. During this workshop, you’ll learn what steps are necessary when driving field medical excellence.

  • Focus on establishing a framework and standards that your team can utilize
  • Discuss how to shape a learning strategy based on the needs of your organization
  • Discuss how the role MSLs is changing and expanding
  • Discover what technologies your peers are leverage technology

Diana Stefani-Hunyady, MD, PhD, MBA, BCMAS - Head of Medical Affairs
Viela Bio


Tuesday, October 22nd, 2019 | Day 1


8:00 AM - 9:00 AM

Registration & Breakfast

9:00 AM - 9:15 AM

Chairperson's Opening Remarks

Eddie G M Power PhD MBANorth America Medical Affairs, Hospital Business
Pfizer Biopharmaceuticals Group

9:15 AM - 10:15 AM

Advisory Board Panel: Work Together in Medical Affairs: Developing an Integrated Medical Affairs Plan

To establish value within your medical affairs team, a well-defined understanding of challenges and opportunities is required. An effective medical affairs strategy enables alignment with clinical development and the commercial function. Cross-functional alignment is critical when bringing value to stakeholders and remaining focused on medical imperatives. 

  • Discover how organizations are restructuring or evolving their medical affairs initiative 
  • Understand how to utilize data generation programs, KOLs, and advisory boards to identify opportunities and build a strategy
  • Explore strategies for Providing scientific guidance to external stakeholder that is easily utilized 

Sarah Lamberth - Director, Integrated Evidence Team Leader-Hematology
Janssen Inc.

Barbara Moehring - Director, Oncology Clinical Development and Medical Affairs
Boehringer Ingelheim

Ike Ogbaa, MD - US Medical Affairs Lead, New Products & Integrated Diabetes Care
Sanofi

10:15 AM - 11:00 AM

Delivering and Implementing the Scientific Platform

  • Establish communication priorities
  • Connect with internal stakeholders
  • Ensure consistent disease state and product communications
  • Define clear, coordinated, and referenced communication points

Tracy Bunting-EarlyDirector, Global Scientific Publications
Pfizer

11:00 AM - 11:15 AM

Networking & Refreshment Break

11:15 AM - 12:15 PM

PANEL: Establishing Effective Review Processes for Scientific & Medical Content Review

  • Sharing best practices when creating review procedures for both medical content 
  • How to identify content that falls under Scientific and Medical Exchange regulations (e.g., Advisory Boards, Medical Information, Congress and Exhibit information)
  • Requirements related to training internal groups to make the process more effective and efficient
  • Understanding what system requirements should be considered when evaluating how to capture review and approval outcomes
  • Ensuring your review process is optimized to handle digital content most effectively
  • Highlighting the importance of establishing effective Medical Content Review processes to organizations that are in the pre-commercial space

Meghan Bagshaw - Senior Director, Global Medical Affairs
Sage Therapeutics

Rebecca Burnett - Executive Director, Strategic Services
Framework Solutions, Inc.

Nami Pandit-Abid, Pharm D, RPh, BCMA - Medical Director, Global Medical Affairs Immunology
Sanofi Genzyme

12:15 PM - 1:15 PM

Networking Lunch

1:15 PM - 2:30 PM

Roundtable Sessions

Roundtable One: Medical Writing & Publications

  • Examine how communication in publications has changed in a digital world
  • Review how your peers are partnering with outsourced writers 
  • Establish project management approaches used for top team communication 
  • Discuss how to navigate a changing regulatory landscape

Ruth Pereira - Publications Leader
AstraZeneca

Roundtable Two: Field Excellence

  • Evaluating the Value of the MSL Team to the Organization
  • Learn how to maintain MSL authenticity under commercial pressures
  • Examine the benefits and risks of disruptive forces within the current pharmaceutical environment
  • Detect how the future of the MSL role will be positively affected
  • Discuss how KPIs and metrics differ based on MSL support across the product lifecycle and the size and longevity of an MSL program
  • Explore how a value message for MSLs that can be effectively shared with key stakeholders

Susan GiacaloneDirector, U.S. Field Medical Affairs
Lexicon Pharmaceuticals, Inc.

Roundtable Three: Discuss Which Electronic Tools Are Best Used to Gather Information for a Robust Strategic Publications Plan

  • Learn how to deliver enriched publication planning outcomes with the use of technology
  • Identify the logistical and resource barriers to domestic and global communication 
  • Master innovative communication solutions to overcome challenges

Marianne Kenny - Vice President, Global Medical Information and Professional Affairs
Actavis Pharma

2:30 PM - 3:15 PM

Leveraging Online Discussion Platforms for Publication Planning Implementation

Within3

3:15 PM - 3:30 PM

Networking & Refreshment Break

3:30 PM - 4:15 PM

Extra Digital Content; Execute Enhanced Technologies to Support Medical Communications

With the medical function drastically evolving, this is undoubtedly an exciting time to work in medical communications. While medical affairs remain the foundation connecting clinical and commercial, much of the role is evolving with a new wave of innovation that is transforming the rules of engagement with customers. This change is creating new and exciting opportunities now and in the future for medical affairs. Learn how to discover digital breakthroughs and innovative technologies being utilized by your peers and explore:

  • The novel ways AI and predictive models are being used to calculate the community impact of a given medical strategy
  • Discuss best practices and the future of digital technology in publications
  • The use of new technologies to improve publication strategy, conference strategy, opinion leader and influencer strategy

Amy CalamariAssociate Director, Oncology Publication Manager
Merck 

4:15 PM - 4:45 PM

Digital Transformation in Medical Information, Future Opportunities and Challenges

Understand the future opportunities and challenges using the different technologies (i.e. Chat, Voice, AI, …etc.) in Pharma industry, to facilitate access to credible/ accurate medical information to HCPs and Patients.

  • Where are we now in the Pharma industry compared to other industries in AI and technology? Are we missing the point?!
  • Discuss the challenges and limitations in the Pharma industry to adapt to newer technologies
  • Explore strategies to prepare the company for better cross-functional alignment to move the industry to digital transformation space

Wagdy Youssef MD, MBA - Director US Medical Communication, Medical Information
Bayer

4:45 PM - 5:15 PM

HCP Engagement Through Live Medical Education Programs

  • Best practices for creative content collaboration with HCPs
  • Establish approaches to evolve from Global to Local program rollout within your company
  • Review how your peers are Navigating Medical Legal Review across 30 + countries

Nami Pandit-Abid, Pharm D, RPh - BCMA Medical Director, Global Medical Affairs Immunology
Sanofi Genzyme

5:15 PM - 5:30 PM

Day One Closing Remarks

Eddie G M Power PhD MBA - Vice President, North America Medical Affairs, Hospital Business
Pfizer Biopharmaceuticals Group


Wednesday, October 23rd, 2019 | Day 2


8:00 AM - 9:00 AM

Networking & Breakfast

9:00 AM - 9:15 AM

Chairperson's Recap of Day One

Stanislav Glezer - VP, Global Medical Affairs – Diabetes Care
BD

9:15 AM - 10:00 AM

Examine Medical Launch Readiness and Strategic Communication Planning

  • How medical affairs can partner with RWE and HEOR teams for commercialization projects  
  • Best practices and strategies for the Medical functions to take during pre-launch
  • Medical insights and how they inform early and long-term brand strategy
  • Discuss how Medical can shape the product and prepare the market for a successful launch

Ashwini Dhume - Director, Publications
Taiho Oncology, Inc.

10:00 AM - 10:45 AM

Beyond Patient-Centricity in Medical Affairs

  • Address the communication requirements of patients as important stakeholder in healthcare decision making
  • Discover how companies are successfully integrating patient-centric strategies
  • Demonstrate a patient perspective by actively considering where in the development of communication tactics there should be patient contribution

Stanislav GlezerVP, Global Medical Affairs – Diabetes Care
BD

 

10:45 AM - 11:00 AM

Networking & Refreshment Break

11:00 AM - 12:00 PM

Panel: Proven Methods for Effectively Solving Misunderstandings and Building Effective Partnerships Between Writers and Author Groups

This discussion will examine tangible recommendations for achieving greater transparency and promoting practices that protect the integrity of authorship and how to best resolve authorship disputes that arise in the development of publications and product messages. We will:

  • Discuss how to reach an author and engage with them to keep them involved in the publication
  • Examine the optimal amount of involvement the sponsor should have in the publication process 
  • Review best practices for addressing when a lead authors make last-minute changes  
  • Discuss conflict in content reviews and how to do moderate disagreement among authors

Ana Bozas, PhD, CMPPAssociate Director Global Medical Communications
Akcea Therapeutics

Burnedette Rose HillDeputy Director, Scientific and Medical Publications
Sanofi Pasteur

12:00 PM - 12:45 PM

Driving Field Medical Excellence – Appropriate MSL Strategies and Tactics to Achieve Success

  • What to leverage as you build your territory and drive impact for your company?
  • What are the key elements to successful internal and external engagement?
  • What drives differentiation leading to a successful career in field medical?

Bob FellExecutive Medical Science Liaison, Diabetes
Sanofi

12:45 PM - 1:00 PM

Chairperson's Closing Remarks

Stanislav Glezer - VP, Global Medical Affairs – Diabetes Care
BD

1:00 PM - 2:00 PM

Networking Lunch


FEATURING

Speakers & Faculty

Eddie Power

Eddie Power

Vice President, North America Medical Affairs, Hospital Business
Pfizer Biopharmaceuticals Group

Jacob Runyan

Jacob Runyan

Director, Scientific Communications
Boehringer Ingelheim

Mina Patel

Mina Patel

Global Head of Publications
Open Health Group

Rebecca Burnett

Rebecca Burnett

Executive Director of Strategic Services
Framework Solutions

Stan Glezer

Stan Glezer

Global Vice President of Medical Affairs, Diabetes Care
Becton Dickinson

Renu Juneja

Renu Juneja

Head of the Scientific Communications and Training
Janssen Biotechnology

Wagdy Youssef

Wagdy Youssef

Director, Medical Affairs Information and Communications
Bayer US

Tracy Bunting-Early

Tracy Bunting-Early

Director, Global Scientific Publications
Pfizer

Bob Fell

Bob Fell

Executive Medical Science Liaison
Sanofi

Ana Bozas

Ana Bozas

Associate Director Global Medical Communication
Akcea Therapeutics

Ashwini Dhume

Ashwini Dhume

Director, Publications
Taiho Oncology, Inc.

Amy Calamari

Amy Calamari

Associate Director, Oncology Publication Manager
Merck

Ruth Pereira

Ruth Pereira

Publications Lead, Cardiovascular and Diabetes Drugs
AstraZeneca

Marianne Kenny

Marianne Kenny

Vice President, Global Medical Information and Professional Affairs
Actavis Pharma

Diane Stefani-Hunyady

Diane Stefani-Hunyady

Head of Medical Affairs
Viela Bio

Susan Giacalone

Susan Giacalone

Director, U.S. Field Medical Affairs
Lexicon Pharmaceuticals, Inc.

Burnedette Rose Hill

Burnedette Rose Hill

Deputy Director, Scientific and Medical Publications
Sanofi Pasteur

Nami Pandit-Abid

Nami Pandit-Abid

Medical Director, Global Medical Affairs Immunology
Sanofi Genzyme

Ike Ogbaa

Ike Ogbaa

US Medical Affairs Lead, New Products & Integrated Diabetes Care
Sanofi

Meghan Bagshaw

Meghan Bagshaw

Senior Director, Global Medical Affairs
Sage Therapeutics

Lance P. Hill

Lance P. Hill

Principal Attorney
Kulkarni Law Firm

Sarah Lamberth

Sarah Lamberth

Director, Integrated Evidence Team Leader-Hematology
Janssen Inc.

Barbara Moehring

Barbara Moehring

Director, Oncology Clinical Development and Medical Affairs
Boehringer Ingelheim

Julia Bohenberger

Julia Bohenberger

Publications Manager
GlaxoSmithKline

Lance P. Hill

Lance P. Hill

Chief Executive Officer
Within3

 
 
 

THREE DAYS OF EDUCATION AND INNOVATION

DON'T MISS IT

REGISTER NOW

REGISTRATION PRICING


CONFERENCE + WORKSHOP

STANDARD

Up to Day of Event

$2,596

ON-SITE

Register On-Site

$2,796

CONFERENCE ONLY

STANDARD

Up to Day of Event

$1,896

ON-SITE

Register On-Site

$2,096

Contact Amy Chapman at 561-571-7687 or achapman@dgevents.com
for pricing packages.

EVENT SPONSORS

SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571.7687
or email achapman@dgeconfs.com

Booth Package Sponsorship

Advertising Package Sponsorship